Literature DB >> 27541662

Clinical and geographic patterns of rheumatic heart disease in outpatients attending cardiology clinic in western Kenya.

Rebecca H Lumsden1, Constantine Akwanalo2, Stella Chepkwony3, Anne Kithei3, Vincent Omollo3, Thomas L Holland4, Gerald S Bloomfield5, Wendy P O'Meara6.   

Abstract

INTRODUCTION: Rheumatic heart disease (RHD) remains a leading cause of cardiovascular mortality in sub-Saharan Africa. Identifying high risk populations and geographic patterns of disease is crucial to developing RHD prevention and screening strategies in endemic areas.
OBJECTIVES: To identify clinical and geographical trends in RHD throughout western Kenya
METHODS: We conducted a retrospective chart review of all patients <50years old attending adult cardiology clinic at a national referral hospital in western Kenya. Demographic information, residential location and cardiac history were collected. We mapped the spatial distribution of cardiac disease rates and analyzed the effect of distance from the hospital on RHD status.
RESULTS: Two-thirds (64%) of cardiology clinic patients <50years old (n=906) had RHD. RHD patients were younger (26 vs. 33years, p<0.001) and more often female (69% vs. 59%, p=0.001) than non-RHD patients. Global clustering of disease rates existed within 200km of the hospital with significant clustering of the RHD and non-RHD rate difference surrounding the hospital (Moran's I: 0.3, p=0.001). There was an interaction between ethnicity and distance from the hospital such that the odds of RHD decreased with further distance for Nilotes, but the odds of RHD increased with further distance for non-Nilotes
CONCLUSION: Most adult cardiology patients treated at a national referral hospital in western Kenya have RHD. Young people and females are commonly affected. Ethnicity and distance to the hospital interdependently affect the odds of RHD. Future studies in this area should consider the impact of ethnic predisposition to RHD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Africa; Epidemiology; Kenya; RHD; Rheumatic heart disease; Valvular disease

Mesh:

Year:  2016        PMID: 27541662     DOI: 10.1016/j.ijcard.2016.08.069

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Clinical, Echocardiographic Characteristics and Management Practices in Patients with Rheumatic Valvular Heart Disease.

Authors:  Temesgen Mulugeta; Kabaye Kumela; Legese Chelkeba
Journal:  Open Access Rheumatol       Date:  2020-10-07

2.  Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception.

Authors:  Caitlin Bernard; Chelsea Pekny; Christabell O Omukagah; Christian O Bernard; Imran Manji; Sonak D Pastakia; Astrid Christoffersen-Deb
Journal:  Contraception       Date:  2018-08-01       Impact factor: 3.375

3.  Impact of regionalisation of a national rheumatic heart disease registry: the Ugandan experience.

Authors:  Emmy Okello; Chris T Longenecker; Amy Scheel; Twalib Aliku; Joselyn Rwebembera; Grace Mirembe; Craig Sable; Peter Lwabi; Andrea Beaton
Journal:  Heart Asia       Date:  2018-01-13

Review 4.  The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.

Authors:  Pasqualina M Coffey; Anna P Ralph; Vicki L Krause
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

5.  High Burden of Cardiac Disease in Pregnancy at a National Referral Hospital in Western Kenya.

Authors:  Rebecca Lumsden; Felix Barasa; Lawrence P Park; Christian B Ochieng; Joy M Alera; Heather C Millar; Gerald S Bloomfield; Astrid Christoffersen-Deb
Journal:  Glob Heart       Date:  2020-02-07

6.  A Bayesian Spatiotemporal Analysis of Pediatric Group A Streptococcal Infections.

Authors:  Angela Wang; Andrew M Fine; Erin Buchanan; Mark Janko; Lise E Nigrovic; Paul M Lantos
Journal:  Open Forum Infect Dis       Date:  2019-12-10       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.